BeOne Medicines Schedules May 6 Release of Q1 2026 Unaudited Results and Audit Committee Review

Bulletin Express

04/22

BeOne Medicines Ltd. will disclose its unaudited financial results for the quarter ended 31 March 2026 on Wednesday, 6 May 2026, after Hong Kong market close. The statements will be prepared under U.S. GAAP and the applicable U.S. SEC rules.

On the same day, the company’s audit committee will meet to review and approve the first-quarter figures.

Management will host a results conference call at 8:00 a.m. U.S. Eastern Time (8:00 p.m. Hong Kong Time) on 6 May 2026. A live webcast and subsequently archived replay will be accessible through the investors section of the company’s website (https://ir.beonemedicines.com). Participants are advised to log in at least 15 minutes before the scheduled start.

The board of directors currently comprises Chairman and Executive Director John V. Oyler; Non-executive Director Dr. Xiaodong Wang; and Independent Non-executive Directors Dr. Olivier Brandicourt, Dr. Margaret Han Dugan, Michael Goller, Anthony C. Hooper, Ranjeev Krishana, Dr. Alessandro Riva, Dr. Corazon D. Sanders, Shalini Sharp and Qingqing Yi.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/news/1144446978"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1144446978\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1144446978?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-22 18:22","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1144446978","market":"us","top_or_hot":-1,"title":"BeOne Medicines Schedules May 6 Release of Q1 2026 Unaudited Results and Audit Committee Review","media":"Bulletin Express","content":"<p>BeOne Medicines Ltd. will disclose its unaudited financial results for the quarter ended 31 March 2026 on Wednesday, 6 May 2026, after Hong Kong market close. The statements will be prepared under U.S. GAAP and the applicable U.S. SEC rules.</p>\n<p>On the same day, the company’s audit committee will meet to review and approve the first-quarter figures.</p>\n<p>Management will host a results conference call at 8:00 a.m. U.S. Eastern Time (8:00 p.m. Hong Kong Time) on 6 May 2026. A live webcast and subsequently archived replay will be accessible through the investors section of the company’s website (https://ir.beonemedicines.com). Participants are advised to log in at least 15 minutes before the scheduled start.</p>\n<p>The board of directors currently comprises Chairman and Executive Director John V. Oyler; Non-executive Director Dr. Xiaodong Wang; and Independent Non-executive Directors Dr. Olivier Brandicourt, Dr. Margaret Han Dugan, Michael Goller, Anthony C. Hooper, Ranjeev Krishana, Dr. Alessandro Riva, Dr. Corazon D. Sanders, Shalini Sharp and Qingqing Yi.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BeOne Medicines Schedules May 6 Release of Q1 2026 Unaudited Results and Audit Committee Review</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBeOne Medicines Schedules May 6 Release of Q1 2026 Unaudited Results and Audit Committee Review\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time smaller\">2026-04-22 18:22</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>BeOne Medicines Ltd. will disclose its unaudited financial results for the quarter ended 31 March 2026 on Wednesday, 6 May 2026, after Hong Kong market close. The statements will be prepared under U.S. GAAP and the applicable U.S. SEC rules.</p>\n<p>On the same day, the company’s audit committee will meet to review and approve the first-quarter figures.</p>\n<p>Management will host a results conference call at 8:00 a.m. U.S. Eastern Time (8:00 p.m. Hong Kong Time) on 6 May 2026. A live webcast and subsequently archived replay will be accessible through the investors section of the company’s website (https://ir.beonemedicines.com). Participants are advised to log in at least 15 minutes before the scheduled start.</p>\n<p>The board of directors currently comprises Chairman and Executive Director John V. Oyler; Non-executive Director Dr. Xiaodong Wang; and Independent Non-executive Directors Dr. Olivier Brandicourt, Dr. Margaret Han Dugan, Michael Goller, Anthony C. Hooper, Ranjeev Krishana, Dr. Alessandro Riva, Dr. Corazon D. Sanders, Shalini Sharp and Qingqing Yi.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06160","symbol_name":"百濟神州","start_time":0,"source_url":"","article_id":"1144446978","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1144446978","pubTimestamp":1776853376,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"BeOne Medicines Ltd. will disclose its unaudited financial results for the quarter ended 31 March 2026 on Wednesday, 6 May 2026, after Hong Kong market close. The statements will be prepared under...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06160":"百济神州"},"translate_title":"BeOne Medicines计划于5月6日发布2026年第一季度未经审计业绩和审计委员会审查","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06160":1},"content_text":"BeOne Medicines Ltd. will disclose its unaudited financial results for the quarter ended 31 March 2026 on Wednesday, 6 May 2026, after Hong Kong market close. The statements will be prepared under U.S. GAAP and the applicable U.S. SEC rules.\nOn the same day, the company’s audit committee will meet to review and approve the first-quarter figures.\nManagement will host a results conference call at 8:00 a.m. U.S. Eastern Time (8:00 p.m. Hong Kong Time) on 6 May 2026. A live webcast and subsequently archived replay will be accessible through the investors section of the company’s website (https://ir.beonemedicines.com). Participants are advised to log in at least 15 minutes before the scheduled start.\nThe board of directors currently comprises Chairman and Executive Director John V. Oyler; Non-executive Director Dr. Xiaodong Wang; and Independent Non-executive Directors Dr. Olivier Brandicourt, Dr. Margaret Han Dugan, Michael Goller, Anthony C. Hooper, Ranjeev Krishana, Dr. Alessandro Riva, Dr. Corazon D. Sanders, Shalini Sharp and Qingqing Yi.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"dataReport,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}